| GTO ID | GTC0942 |
| Trial ID | ChiCTR2100050387 |
| Disease | Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | radiotherapy |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Safety and efficacy of radiotherapy combined with CAR-T immunotherapy for high-risk lymphoid malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Xiangya Bo'ai Rehabilitation Hospital |
| Cohort 1 | |||||||
|
|||||||